948 related articles for article (PubMed ID: 32460812)
21. Forward single-cell sequencing into clinical application: Understanding of cancer microenvironment at single-cell solution.
Liu X; Powell CA; Wang X
Clin Transl Med; 2022 Apr; 12(4):e782. PubMed ID: 35474615
[TBL] [Abstract][Full Text] [Related]
22. Genomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenografts.
Wei L; Chintala S; Ciamporcero E; Ramakrishnan S; Elbanna M; Wang J; Hu Q; Glenn ST; Murakami M; Liu L; Gomez EC; Sun Y; Conroy J; Miles KM; Malathi K; Ramaiah S; Anbarasu A; Woloszynska-Read A; Johnson CS; Conroy J; Liu S; Morrison CD; Pili R
Oncotarget; 2016 Nov; 7(47):76374-76389. PubMed ID: 27823983
[TBL] [Abstract][Full Text] [Related]
23. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
[TBL] [Abstract][Full Text] [Related]
24. Single-cell RNA sequencing reveals the cellular and molecular characteristics of high-grade and metastatic bladder cancer.
Zheng Y; Wang X; Yang X; Xing N
Cell Oncol (Dordr); 2023 Oct; 46(5):1415-1427. PubMed ID: 37170046
[TBL] [Abstract][Full Text] [Related]
25. Single-cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer.
Lai H; Cheng X; Liu Q; Luo W; Liu M; Zhang M; Miao J; Ji Z; Lin GN; Song W; Zhang L; Bo J; Yang G; Wang J; Gao WQ
Int J Cancer; 2021 Dec; 149(12):2099-2115. PubMed ID: 34480339
[TBL] [Abstract][Full Text] [Related]
26. Complete response to anti-PD-L1 antibody in a metastatic bladder cancer associated with novel MSH4 mutation and microsatellite instability.
Yang Y; Jain RK; Glenn ST; Xu B; Singh PK; Wei L; Hu Q; Long M; Hutson N; Wang J; Battaglia S; George S
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32221012
[TBL] [Abstract][Full Text] [Related]
27. CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance.
Afonso J; Santos LL; Miranda-Gonçalves V; Morais A; Amaro T; Longatto-Filho A; Baltazar F
Mol Carcinog; 2015 Nov; 54(11):1451-66. PubMed ID: 25263481
[TBL] [Abstract][Full Text] [Related]
28. Cancer biology deciphered by single-cell transcriptomic sequencing.
Li Y; Jin J; Bai F
Protein Cell; 2022 Mar; 13(3):167-179. PubMed ID: 34405376
[TBL] [Abstract][Full Text] [Related]
29. Integrating microarray-based spatial transcriptomics and single-cell RNA-sequencing reveals tissue architecture in esophageal squamous cell carcinoma.
Guo W; Zhou B; Yang Z; Liu X; Huai Q; Guo L; Xue X; Tan F; Li Y; Xue Q; Gao S; He J
EBioMedicine; 2022 Oct; 84():104281. PubMed ID: 36162205
[TBL] [Abstract][Full Text] [Related]
30. Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single-cell transcriptomics.
Tirier SM; Mallm JP; Steiger S; Poos AM; Awwad MHS; Giesen N; Casiraghi N; Susak H; Bauer K; Baumann A; John L; Seckinger A; Hose D; Müller-Tidow C; Goldschmidt H; Stegle O; Hundemer M; Weinhold N; Raab MS; Rippe K
Nat Commun; 2021 Nov; 12(1):6960. PubMed ID: 34845188
[TBL] [Abstract][Full Text] [Related]
31. A Phase II Trial of Tipifarnib for Patients with Previously Treated, Metastatic Urothelial Carcinoma Harboring
Lee HW; Sa JK; Gualberto A; Scholz C; Sung HH; Jeong BC; Choi HY; Kwon GY; Park SH
Clin Cancer Res; 2020 Oct; 26(19):5113-5119. PubMed ID: 32636318
[TBL] [Abstract][Full Text] [Related]
32. Atezolizumab in invasive and metastatic urothelial carcinoma.
Crist M; Balar A
Expert Rev Clin Pharmacol; 2017 Dec; 10(12):1295-1301. PubMed ID: 28994323
[TBL] [Abstract][Full Text] [Related]
33. Whole transcriptome profiling of patient-derived xenograft models as a tool to identify both tumor and stromal specific biomarkers.
Bradford JR; Wappett M; Beran G; Logie A; Delpuech O; Brown H; Boros J; Camp NJ; McEwen R; Mazzola AM; D'Cruz C; Barry ST
Oncotarget; 2016 Apr; 7(15):20773-87. PubMed ID: 26980748
[TBL] [Abstract][Full Text] [Related]
34. Towards Personalized Neoadjuvant Therapy for Muscle-invasive Bladder Cancer.
Li R; Spiess PE; Gilbert SM; Necchi A
Eur Urol; 2019 Jul; 76(1):4-6. PubMed ID: 30833139
[TBL] [Abstract][Full Text] [Related]
35. Single-cell RNA-seq analysis identifies markers of resistance to targeted BRAF inhibitors in melanoma cell populations.
Ho YJ; Anaparthy N; Molik D; Mathew G; Aicher T; Patel A; Hicks J; Hammell MG
Genome Res; 2018 Sep; 28(9):1353-1363. PubMed ID: 30061114
[TBL] [Abstract][Full Text] [Related]
36. Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis.
Snyder A; Nathanson T; Funt SA; Ahuja A; Buros Novik J; Hellmann MD; Chang E; Aksoy BA; Al-Ahmadie H; Yusko E; Vignali M; Benzeno S; Boyd M; Moran M; Iyer G; Robins HS; Mardis ER; Merghoub T; Hammerbacher J; Rosenberg JE; Bajorin DF
PLoS Med; 2017 May; 14(5):e1002309. PubMed ID: 28552987
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneity of cancer-associated fibroblasts: Opportunities for precision medicine.
Kanzaki R; Pietras K
Cancer Sci; 2020 Aug; 111(8):2708-2717. PubMed ID: 32573845
[TBL] [Abstract][Full Text] [Related]
38. Single-cell RNA sequencing in cancer research.
Zhang Y; Wang D; Peng M; Tang L; Ouyang J; Xiong F; Guo C; Tang Y; Zhou Y; Liao Q; Wu X; Wang H; Yu J; Li Y; Li X; Li G; Zeng Z; Tan Y; Xiong W
J Exp Clin Cancer Res; 2021 Mar; 40(1):81. PubMed ID: 33648534
[TBL] [Abstract][Full Text] [Related]
39. Emerging role of immunotherapy in urothelial carcinoma-Immunobiology/biomarkers.
Sweis RF; Galsky MD
Urol Oncol; 2016 Dec; 34(12):556-565. PubMed ID: 27836246
[TBL] [Abstract][Full Text] [Related]
40. Estimation of immune cell content in tumor using single-cell RNA-seq reference data.
Yu X; Chen YA; Conejo-Garcia JR; Chung CH; Wang X
BMC Cancer; 2019 Jul; 19(1):715. PubMed ID: 31324168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]